SA I/II (10-to when tested by the solidphase radioimmunoassay. Cross-reactive antibodies to heart homogenates (HH) were not elicited in rhesus monkeys. A few rabbits immunized with cell wall or SA II preparation in Freund complete adjuvant followed by the incomplete adjuvant yielded low antibody titers (up to 10-2) to the HH. The specificity of the putative heart cross-reactive antibodies was tested by immunoadsorption with related and unrelated antigens. Whereas antibody to SA I/II showed specific adsorption with SA I/II but not with HH, immunoglobulin G, or the unrelated antigens, antibody to HH seemed to have been adsorbed with all of the related and unrelated antigens. There was no evidence for the development of heart cross-reactive antibodies on immunization of rhesus monkeys or rabbits with SA I/II and aluminium hydroxide or Freund incomplete adjuvant, administered by the subcutaneous or intramuscular route in doses of up to 13 mg of the immunogen.
Immunization of rabbits and rhesus monkeys with Streptococcus mutans whole cells, cell walls, and defined streptococcal antigens (SAs) SA I/MI, SA I, and SA II resulted in high antibody titers to SA I/II (10-to when tested by the solidphase radioimmunoassay. Cross-reactive antibodies to heart homogenates (HH) were not elicited in rhesus monkeys. A few rabbits immunized with cell wall or SA II preparation in Freund complete adjuvant followed by the incomplete adjuvant yielded low antibody titers (up to to the HH. The specificity of the putative heart cross-reactive antibodies was tested by immunoadsorption with related and unrelated antigens. Whereas antibody to SA I/II showed specific adsorption with SA I/II but not with HH, immunoglobulin G, or the unrelated antigens, antibody to HH seemed to have been adsorbed with all of the related and unrelated antigens. There was no evidence for the development of heart cross-reactive antibodies on immunization of rhesus monkeys or rabbits with SA I/II and aluminium hydroxide or Freund incomplete adjuvant, administered by the subcutaneous or intramuscular route in doses of up to 13 mg of the immunogen.
Successful immunization against Streptococcus mutans in the prevention of dental caries has been achieved in both rodents (18, 19, 24, 26) and monkeys (3, 12, 16, 17, 23) . Salivary immunoglobulin A (IgA) antibodies to S. mutans have been emphasized in the protective mechanism in rodents (18, 26) . Of the three major classes of serum antibodies to S. mutans characterized in rhesus monkeys, IgG appeared to be particularly important (14) , and the antibodies have now been demonstrated in gingival crevicular fluid (25) . Cellular immunity has also been investigated in rhesus monkeys, and these have shown skin delayed hypersensitivity lymphocyte transformation and macrophage migration inhibition in the immunized and protected monkeys (14) . Furthermore, streptococcal antigenspecific helper and suppressor functions were found in immunized monkeys (9, 10, 15) and in humans (11) .
An essential prerequisite in vaccination is that it be free of any side effects. Hyperimmunization studies in rabbits, in which they received 9 to 18 consecutive intravenous (i.v.) injections of cells of S. mutans (5, 7, 27) (7, 27) , and fused rocket and crossed immunoelectrophoresis (IEP) have also suggested that S. mutans shares some cross-reactive antigen with heart tissue (5, 7).
We have therefore investigated adverse reactions in rhesus monkeys, immunized under conditions comparable to those used in human vaccination, and in rabbits immunized or hyperimmunized with a variety of S. mutans antigens. The objective was to find out whether under these conditions of immunization with streptococcal antigens, cross-reactive heart antibodies could be induced. 20 ,000 x g. Protein antigens were prepared by ammonium sulfate precipitation of the culture fluid, followed by ionexchange and gel filtration chromatography as previously described (20) (21) (22) .
Heart tissue homogenate. Heart tissue was obtained at autopsy within 12 h of death from causes unrelated to heart disease. The tissue was cut into small pieces, and the surfaces were seared in a Bunsen flame. The seared surfaces were cut away and discarded. Sterile technique was then used throughout. The inner tissue was sliced, washed three times in sterile saline at 4°C, and snap-frozen in liquid nitrogen. The tissue was then ground in dry ice, thawed, and made up to 100 ml with sterile saline. The resulting solution was examined for bacterial contamination by plating onto blood agar and Trypticase yeast culture medium. The preparation was lyophilized in 10-ml Table 2 , group 7). A fourth SC injection of 0.1 mg of SA II in FIA was given to two rabbits, and 1 mg in FIA was given to one rabbit ( Table  2 , group 7a). The rabbits were bled routinely through the marginal ear vein 1 to 2 weeks after the last injection and then at approximately monthly intervals. The serum was separated and stored at -20°C. The data presented were selected for the highest titers of antibodies to the heart homogenate (HH). A reference antiserum to human HH was raised in rabbits by immunization with 10 mg of the freeze-dried HH administered i.m. in FCA, followed at intervals of 3 weeks by five SC injections of 10 mg in FIA.
(ii) Rhesus monkeys. A total of 33 rhesus monkeys were divided into nine groups and were caged and maintained on a human type of diet as described previously (13) . Blood was collected from the femoral vessels, and the serum was separated and stored at -20'C. Three monkeys were given 5 x 108 cells of S. mutans (Guy's strain) in FIA SC, followed 16 weeks later by 5 x 108 cells without the adjuvant (Table 3, group 1). Another group of three monkeys received 5 x 108 formalinized whole cells of S. mutans (Ingbritt strain) in FCA i.m., followed 4 and 8 weeks later by an injection of 5 x 108 cells without the adjuvant (Table 3, group 2). Six monkeys (Table 3 , group 3) were given 5 x 108 formalinized whole cells of S. mutans (Ingbritt) in FIA by the SC route, followed by five injections of 5 x 108 cells without the adjuvant at intervals of 4, 8, 12, 16, and 36 weeks. Six monkeys received a SC injection of 5 mg offreeze-dried cell walls in FIA each, followed at 8 and 30 weeks by 5 and 10 mg of the cell walls without the adjuvant (Table 3 , group 4). SA l/l, I, or Il was administered to 12 monkeys SC (Table 4) , of which 7 were injected with SA I/IH. Three monkeys received 0.6 mg in FIA by the SC route, followed 36 weeks later by 0.6 mg of SA I/l but without the adjuvant (Table 4 , group 6). Three monkeys received 10 mg of SA MI/I, two in FIA and one in aluminium hydroxide by the SC route, followed by 2 and 1 mg at weeks 25 and 64, respectively; another monkey received 10, 5, and 10 mg of SA I/Il at weeks 0, 12, and 64, respectively, without adjuvant (Table 4 , group 7). SA I was administered SC to three monkeys in a dose of 0.5 mg in FIA, followed 8 weeks later by 0.1 mg without adjuvant ( (25) . The concentration of HH required to coat the tubes was titrated by using 1 to 20
Fg of the preparation and the anti-heart antiserum.
The optimal concentration was 5 to 10 ,ug/ml, and 10 p.g was added in all subsequent assays. Test antisera were serially diluted in phosphate-buffered saline with 0.5% bovine serum albumin and 0.05% Tween 20 and were incubated for 3 h at 37°C. After washing, swine anti-rabbit immunoglobulin, detecting IgG, IgM, and IgA (Dako Immunoglobulins AS Copenhagen, Denmark), or rabbit anti-monkey Fc (IgG) antiserum (prepared in this department), was added and incubated for 2 h at 37°C. The monkey IgG was prepared by digestion with papain, and the Fc gamma fragment was separated by ion-exchange chromatography (6) . Rabbits were immunized with this preparation and yielded monospecific anti-Fc gamma globulin antisera. The two developing antisera were iodinated by the chloramine T method (8) for use in the radioimmunoassay.
Radioimmunoassay of antibodies to HH adsorbed by a variety of antigens. The radioimmunoassay of antibodies to HH was carried out with cyanogen bromideactivated beads, coated with six related and unrelated antigens ( To remove the weakly bound protein, the immunoadsorbents were washed in 6 M guanidinium hydrochloride. The beads were then washed thoroughly in 0.1 M phosphate buffer containing 0.5 M NaCI (pH 7.4). The sera were then adsorbed by incubating 1 ml of the packed immunoadsorbent beads with 0.5 ml of serum for 1 h at 37°C, followed by overnight incubation at 4°C on a rotating turntable. The adsorbed sera were removed by centrifugation at 350 x g for 5 min and were stored at -20°C until assayed. RESULTS Antibodies to SA I/II and to the HH in sera from rabbits immunized with streptococcal antigens. All sera from immunized rabbits showed antibody titers to SA I/MI greater than t0-5 (Tables 1 and 2 HEART ANTIBODIES AND S. MUTANS IMMUNIZATION 1079 6). Furthermore, a comparative titration of the SA 1/11-immunized group of five rabbits showed that whereas antibodies to SA I/II were detectable at a serum dilution of 10-6, no significant antibodies were detected to the HH (Fig. 1) . A control rabbit antiserum to the heart homogenate showed 3.6% binding at a serum dilution of 10-2, and antibodies were detectable at a serum dilution of l0-5, so that the sensitivity of the assay was established. Antibodies to SA I/I and the HH in sera from rhesus monkeys immunized with streptococcal antigens. All sera from monkeys immunized with S. mutans two, three, or six times i.v. with 1 x 109 to 3 x 109 cells in FCA or FIA showed high percentages of binding of antibodies to SA I/II (Table 3, groups 1, 2, and 3 ). Significant serum antibody titers of up to 10-4 were found in these monkeys, and similar results were found in S. mutans cell wall immunized monkeys (Table 3 , group 4). There was little or no increase in antibodies to SA I/IT in the sham-immunized monkeys (Table 3 , group 5). Unlike the high antibody titers to SA I/II, none of the monkeys showed significantly greater antibody titers to the HH than those found in the preimmune sera (Fig. 2) . The positive anti-heart antibody control rabbit serum yielded a titer of 10-5 to the HH.
Immunization with SA I/TI, I, or II in aluminium hydroxide or FIA once, twice, or three times again caused high titers of serum antibodies to SA I/II (up to (Tables 1 and 2) . A low antibody titer (up to 10-2) to the HH was found in a few sera from rabbits immunized with cell walls or SA II. Although a positive control rabbit antiserum to HH yielded a titer of 10-5 in the same assay, it is nevertheless possible that the assay lacked sufficient sensitivity to detect very low-titer antibodies to HH. A comparative x.e. titration of the SA I/II-immunized group of five rabbits showed that whereas serum antibodies to SA I/TI reached a titer greater than 10-5, no antibodies were detectable to the HH (Fig. 1) . A parallel investigation of 30 rhesus monkeys was carried out, using two to six injections of the streptococcal antigens (Tables 3 and 4 ). Most immunized monkeys had antibody titers to SA I/TI greater than 1O-4, but none had any detect- (Fig. 2) . As SA I/IT induces protection against dental caries with doses of 0.1 mg (16, 17) , it is especially significant that SA I/II failed to induce antibodies to HH when monkeys were injected with up to 25 mg of SA M/II. Furthermore, our experience in vaccination of rhesus monkeys under clinically acceptable conditions over a period of 10 years revealed no adverse effects in health, weight, haematological indices, or at the site of administration of the vaccine.
Although the significance of the very low antibody titers to HH in a few rabbits was rather doubtful, this had been further investigated. Comparative immunoadsorption studies showed that whereas specific adsorption resulted with anti-SA I/MI antibodies, this could not be demonstrated with the low-titer anti-HH antibodies (Table 5) .
A brief review of the literature on the potential cross-reactivity between S. mutans and heart tissue is warranted, as the results differ in some respects from those described in this paper. We failed to induce in rabbits antibodies to the HH after 6 or times were necessary to detect antibodies which precipitated with HH in crossed IEP (7) . Less intense schedules failed to induce cross-reactive antibodies in rabbits, monkeys, and rats. In another study (5), 14 IEP, or by adding streptococcal antigen to heart antigen in crossed IEP (1) .
Much of the evidence was based on a slight "'pull-down" effect by using a complex intermediate gel technique in which both the timing and the current varied, and there was little indication that the same reagents were used in the comparative tests (7) . The significance of a minor change in mobility could not be interpreted in the absence of an essential control, using unrelated antiserum (e.g., 18 i.v. injections with other antigens). Even under these conditions, one of the two putative cross-reactive antigens (HL2) failed to be absorbed, and no evidence was presented that the limited "pull-down" effect with the other antigen (HL1) was significant, if an unrelated antigen were to be used under the same conditions as a control.
In another experiment (5) , some pre-immunization sera from normal rabbits demonstratece heart antibodies which became more prominent after 14 i.v. injections, suggesting an anamnestic reaction to that antigen. It is also noteworthy that it was necessary to adsorb the antiserum five times with S. mutans to eliminate the heart cross-reactive antibodies, although they 
